CardioMech AS, a privately held company developing a transcatheter mitral valve repair technology, today announced it has expanded its leadership team with the election of two new board directors − Kathleen Tune of Fourth Element Capital, and Frederik Groenewegen of 415 CAPITAL, a board advisor, Vic Bertrand and appointed Daniele Salamone as Vice President of Finance.
The CardioMech device is a highly differentiated technology designed to significantly improve the standard of care for patients suffering from severe, symptomatic degenerative mitral regurgitation due to prolapse or flail. “I am extremely pleased to announce this expansion of CardioMech’s mitral leadership team with the addition of four experienced medical technology professionals,” said Rick Nehm, President and CEO of CardioMech.
Kathleen is a proven healthcare executive with over 25 years of investing and business experience. She co-founded and manages ahealthcare investment firm Fourth Element Capitaland previously was a partner at the healthcare investment firm Thomas, McNerney & Partners.“CardioMech is participating in one of the most innovative segments of medicine with a significant unmet need,” said KathleenTune.Frederik, co-founder and managing director of 415 CAPITAL, a designated medical technologyinvestment firm whose senior team has backed over 45 novel medical device technologies, including CoreValve (Medtronic), CardiAQ (Edwards Lifesciences), and Claret (Boston Scientific).
Frederik brings extensive fundraising, M&A and commercialization experience to the CardioMech team. “Transcatheter mitral valve repair is a hot market segment,and we believe CardioMech is strongly positioned fora leadership role in chordal repair,”said FrederikGroenewegen.
Vic, a veteranmedical technologyinvestor and directorwhowas appointed as aCardioMechAdvisor, is also an entrepreneur with30 years’ experience in medical technology, manufacturing, and real estate, said, “I am thrilled to support Rick and the CardioMech team on their mission to bring this innovative and much needed solution to the affected population globally,”said Vic Bertrand.
Daniele Salamone, CardioMech’snew Vice President of Finance, brings tremendous experience to the company to accelerate and guide the creation of shareholder value. He is an experienced strategy consultant with expertise in corporate development, strategic planning,and M&A transactions. His background is in innovation with startups and corporateinnovation initiatives. He has direct experience withstructural heartdevice commercialization. Hewas most recently atThe Boston Consulting Group